Proteomic understanding of SARS-CoV-2 infection and COVID-19: Biological, diagnostic, and therapeutic perspectives

Fares Al-Ejeh, Maysaloun Merhi, Mariam Al-Muftah, Queenie Fernandes, Lobna Al-Zaidan, Takwa Bedhiafi, Sarra Mestiri, Dina Moustafa, Nassiba Taib, Varghese Inchakalody, Afsheen Raza, Shahab Uddin, Said Dermime

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Citation (Scopus)

Abstract

The research community responded rapidly to the SARS-CoV-2 pandemic with a burst of proteomic studies to understand this new virus. We focus in this chapter on proteomic approaches and advances in the areas of the viral proteome and the viral-host protein-protein interactions exploited to facilitate the pathogenic life cycle of SARS-CoV2. We also outline the proteome and posttranslational protein modifications of infected cells and blood proteomics of COVID-19 patients in relation to pathogenesis, host response, and disease severity. Finally, tools and application for COVID-19 proteomics and implementations in diagnostics and therapies are surveyed before summarizing the present achievements and future perspectives.

Original languageEnglish
Title of host publicationOmics Approaches and Technologies in COVID-19
PublisherElsevier
Pages61-85
Number of pages25
ISBN (Electronic)9780323917940
ISBN (Print)9780323986212
DOIs
Publication statusPublished - 1 Jan 2022

Keywords

  • COVID-19
  • Posttranslational modifications (PTMs)
  • Protein-protein interactions (PPIs)
  • Proteome
  • Proteomic
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Proteomic understanding of SARS-CoV-2 infection and COVID-19: Biological, diagnostic, and therapeutic perspectives'. Together they form a unique fingerprint.

Cite this